Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Bio-Rad revenue increased from $2.3 billion in 2019 to $2.5 billion in 2020, a (10.1%) increase.

Annual Revenue ($)

Bio-Rad revenue was $2.55 b in FY, 2020 which is a (10.1%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2018FY, 2019FY, 2020
Revenue$2.29 b$2.31 b$2.55 b
Growth6.00%0.97%10.12%
Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021
Revenue$553.98 m$572.62 m$560.63 m$571.64 m$536.88 m$647.26 m$726.8 m$715.93 m$747.05 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Bio-Rad revenue breakdown by business segment: 51.3% from Clinical Diagnostics, 48.4% from Life Science and 0.3% from Other

Bio-Rad revenue breakdown by geographic segment: 33.7% from Europe, 39.5% from United States, 5.4% from Other (primarily Canada and Latin America) and 21.5% from Asia

Q3, 2021Q1, 2020FY, 2018Q3, 2020Q2, 2020Q1, 2019Q2, 2019Q2, 2021Q3, 2019Q1, 2021FY, 2020FY, 2019
Clinical Diagnostics$372.2 m$340.3 m$1.41 b$322.2 m$283.2 m$334.1 m$357.1 m$380.2 m$341.8 m$358.5 m$1.31 b$1.41 b
Other$1.3 m$4.1 m$15.9 m$1.1 m$1.6 m$4.2 m$3.1 m$1.5 m$3.1 m$1.8 m$8.6 m$13.8 m
Life Science$373.5 m$227.2 m$861.7 m$324 m$252.1 m$215.7 m$212.4 m$334.2 m$215.7 m$366.5 m$1.23 b$885.9 m
Q3, 2021Q1, 2020FY, 2018Q3, 2020Q2, 2020Q1, 2019Q2, 2019Q2, 2021Q3, 2019Q1, 2021FY, 2020FY, 2019
Europe$221.5 m$195.7 m$792 m$220.9 m$174 m$185.9 m$188.2 m$229.1 m$181.9 m$247.7 m$857.7 m$770.3 m
United States$315.4 m$229.5 m$863.6 m$250.4 m$205.4 m$226.1 m$222.1 m$274.6 m$225.8 m$271.4 m$1 b$899.1 m
Other (primarily Canada and Latin America)$38.9 m$35 m$138.3 m$34 m$28.5 m$35.6 m$35 m$40.1 m$32.2 m$38.8 m$136.6 m$137.3 m
Asia$171.2 m$111.4 m$142 m$129 m$127.3 m$172.1 m$120.7 m$168.9 m$546.5 m$505 m
Pacific Rim$495.5 m$106.4 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu